779 related articles for article (PubMed ID: 26948651)
1. Inhibition of spleen tyrosine kinase (syk) suppresses renal fibrosis through anti-inflammatory effects and down regulation of the MAPK-p38 pathway.
Chen KH; Hsu HH; Yang HY; Tian YC; Ko YC; Yang CW; Hung CC
Int J Biochem Cell Biol; 2016 May; 74():135-44. PubMed ID: 26948651
[TBL] [Abstract][Full Text] [Related]
2. Noscapine alleviates unilateral ureteral obstruction-induced inflammation and fibrosis by regulating the TGFβ1/Smads signaling pathways.
Hung CC; Chen KH; Hsu HH; Chang MY; Ko YC; Yang HY; Yang CW
Biochim Biophys Acta Mol Cell Res; 2024 Jan; 1871(1):119594. PubMed ID: 37730129
[TBL] [Abstract][Full Text] [Related]
3. The AMPK agonist AICAR inhibits TGF-β1 induced activation of kidney myofibroblasts.
Chen KH; Hsu HH; Lee CC; Yen TH; Ko YC; Yang CW; Hung CC
PLoS One; 2014; 9(9):e106554. PubMed ID: 25188319
[TBL] [Abstract][Full Text] [Related]
4. You-gui Pill ameliorates renal tubulointerstitial fibrosis via inhibition of TGF-β/Smad signaling pathway.
Wang L; Cao AL; Chi YF; Ju ZC; Yin PH; Zhang XM; Peng W
J Ethnopharmacol; 2015 Jul; 169():229-38. PubMed ID: 25922264
[TBL] [Abstract][Full Text] [Related]
5. Astragaloside IV inhibits renal tubulointerstitial fibrosis by blocking TGF-β/Smad signaling pathway in vivo and in vitro.
Wang L; Chi YF; Yuan ZT; Zhou WC; Yin PH; Zhang XM; Peng W; Cai H
Exp Biol Med (Maywood); 2014 Oct; 239(10):1310-24. PubMed ID: 24879422
[TBL] [Abstract][Full Text] [Related]
6. A role for spleen tyrosine kinase in renal fibrosis in the mouse obstructed kidney.
Ma FY; Blease K; Nikolic-Paterson DJ
Life Sci; 2016 Feb; 146():192-200. PubMed ID: 26779657
[TBL] [Abstract][Full Text] [Related]
7. Anti-renal fibrosis effect of asperulosidic acid via TGF-β1/smad2/smad3 and NF-κB signaling pathways in a rat model of unilateral ureteral obstruction.
Xianyuan L; Wei Z; Yaqian D; Dan Z; Xueli T; Zhanglu D; Guanyi L; Lan T; Menghua L
Phytomedicine; 2019 Feb; 53():274-285. PubMed ID: 30668407
[TBL] [Abstract][Full Text] [Related]
8. Deubiquitinase inhibitor PR-619 reduces Smad4 expression and suppresses renal fibrosis in mice with unilateral ureteral obstruction.
Soji K; Doi S; Nakashima A; Sasaki K; Doi T; Masaki T
PLoS One; 2018; 13(8):e0202409. PubMed ID: 30114247
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of p38 mitogen-activated protein kinases attenuates renal interstitial fibrosis in a murine unilateral ureteral occlusion model.
Gao F; Wang Y; Li S; Wang Z; Liu C; Sun D
Life Sci; 2016 Dec; 167():78-84. PubMed ID: 27773718
[TBL] [Abstract][Full Text] [Related]
10. pNaKtide ameliorates renal interstitial fibrosis through inhibition of sodium-potassium adenosine triphosphatase-mediated signaling pathways in unilateral ureteral obstruction mice.
Cheng X; Song Y; Wang Y
Nephrol Dial Transplant; 2019 Feb; 34(2):242-252. PubMed ID: 29788096
[TBL] [Abstract][Full Text] [Related]
11. Pirfenidone suppresses MAPK signalling pathway to reverse epithelial-mesenchymal transition and renal fibrosis.
Li Z; Liu X; Wang B; Nie Y; Wen J; Wang Q; Gu C
Nephrology (Carlton); 2017 Aug; 22(8):589-597. PubMed ID: 27245114
[TBL] [Abstract][Full Text] [Related]
12. Hepatocyte growth factor suppresses renal interstitial myofibroblast activation and intercepts Smad signal transduction.
Yang J; Dai C; Liu Y
Am J Pathol; 2003 Aug; 163(2):621-32. PubMed ID: 12875981
[TBL] [Abstract][Full Text] [Related]
13. Tamoxifen ameliorates renal tubulointerstitial fibrosis by modulation of estrogen receptor α-mediated transforming growth factor-β1/Smad signaling pathway.
Kim D; Lee AS; Jung YJ; Yang KH; Lee S; Park SK; Kim W; Kang KP
Nephrol Dial Transplant; 2014 Nov; 29(11):2043-53. PubMed ID: 25031017
[TBL] [Abstract][Full Text] [Related]
14. Apamin inhibits renal fibrosis via suppressing TGF-β1 and STAT3 signaling in vivo and in vitro.
Gwon MG; An HJ; Gu H; Kim YA; Han SM; Park KK
J Mol Med (Berl); 2021 Sep; 99(9):1265-1277. PubMed ID: 34031696
[TBL] [Abstract][Full Text] [Related]
15. IN-1130, a novel transforming growth factor-beta type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy.
Moon JA; Kim HT; Cho IS; Sheen YY; Kim DK
Kidney Int; 2006 Oct; 70(7):1234-43. PubMed ID: 16929250
[TBL] [Abstract][Full Text] [Related]
16. Dihydroquercetin protects against renal fibrosis by activating the Nrf2 pathway.
Wang W; Ma BL; Xu CG; Zhou XJ
Phytomedicine; 2020 Apr; 69():153185. PubMed ID: 32120244
[TBL] [Abstract][Full Text] [Related]
17. Low-dose paclitaxel ameliorates renal fibrosis by suppressing transforming growth factor-β1-induced plasminogen activator inhibitor-1 signaling.
Jung ES; Lee J; Heo NJ; Kim S; Kim DK; Joo KW; Han JS
Nephrology (Carlton); 2016 Jul; 21(7):574-82. PubMed ID: 26869361
[TBL] [Abstract][Full Text] [Related]
18. Delayed inhibition of p38 mitogen-activated protein kinase ameliorates renal fibrosis in obstructive nephropathy.
Nishida M; Okumura Y; Sato H; Hamaoka K
Nephrol Dial Transplant; 2008 Aug; 23(8):2520-4. PubMed ID: 18515792
[TBL] [Abstract][Full Text] [Related]
19. Piceatannol Attenuates Renal Fibrosis Induced by Unilateral Ureteral Obstruction via Downregulation of Histone Deacetylase 4/5 or p38-MAPK Signaling.
Choi SY; Piao ZH; Jin L; Kim JH; Kim GR; Ryu Y; Lin MQ; Kim HS; Kee HJ; Jeong MH
PLoS One; 2016; 11(11):e0167340. PubMed ID: 27902771
[TBL] [Abstract][Full Text] [Related]
20. Herb pair of Rhubarb-Astragalus mitigates renal interstitial fibrosis through downregulation of autophagy via p38-MAPK/TGF-β1 and p38-MAPK/smad2/3 pathways.
Li J; Qin X; Xu W; Zhang H; Huang S; Yang Y; Qin M; Mi Z; Zhong X
Int J Biochem Cell Biol; 2024 Apr; 169():106549. PubMed ID: 38340950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]